The research, conducted between 2022 and 2024, set out to answer a deceptively simple question: does chronic infection with this filarial worm change how the human immune system responds to the virus that causes COVID-19? Helminths are master manipulators of host immunity. To survive for years, sometimes decades, inside their hosts, filarial parasites actively dampen inflammatory pathways, skew immune responses toward a so-called Th2 profile dominated by allergy-associated and regulatory signaling, and elevate immunosuppressive cytokines. This immunological recalibration helps the worm, but it may also alter how the host handles unrelated threats, including viruses and vaccines.

Loiasis presents in two immunologically distinct forms, and the Gabonese study took advantage of that distinction. In microfilaremic loiasis, microscopic larvae called microfilariae circulate in the peripheral blood, representing an active, patent infection in which the parasites are reproducing and exposing the immune system to a continuous stream of worm antigens. In amicrofilaremic, or occult, loiasis, a person has a documented history of eyeworm migration but no detectable larvae in the blood, a state thought to reflect a different balance between parasite and host defenses. Because the two forms likely impose different degrees of immune modulation, separating them allowed the researchers to ask whether the burden of active microfilaremia, rather than past exposure to the worm, was what mattered for antiviral immunity.

The study enrolled 192 participants, who were sorted into three groups: 43 with microfilaremic loiasis, 59 with occult loiasis, and 90 with no evidence of active loiasis. Classification relied on established field diagnostics. Microfilaremia was confirmed by microscopy of stained blood smears, the traditional gold standard for detecting and quantifying circulating larvae. Occult disease was identified using the Rapid Assessment Procedure for Loiasis, a tool designed for endemic settings where blood-smear screening alone may miss infected individuals. This careful phenotyping matters, because misclassifying participants would blur exactly the contrast the investigators hoped to detect.

To probe antiviral immunity, the team measured two arms of the adaptive immune response. Antibody responses were assessed by measuring SARS-CoV-2-specific IgG directed against the viral spike and nucleocapsid proteins using enzyme-linked immunosorbent assays, or ELISA. T cell reactivity, meanwhile, was gauged with an interferon-gamma release assay, a technique that detects the release of IFN-γ, a signature proinflammatory cytokine, from T cells after stimulation with spike antigen in vitro. The combination is informative: antibodies reflect one facet of immune memory, while IFN-γ production reflects the cellular arm that coordinates antiviral defense and is central to clearing infected cells.

The results revealed a striking asymmetry. IFN-γ responses were significantly reduced in microfilaremic individuals compared with the other participants, a difference that reached statistical significance at p equal to 0.031. When the analysis was refined across all three groups, the contrast sharpened further: IFN-γ responses were lower in the microfilaremic group than in the occult loiasis group, with p equal to 0.012. In other words, the presence of circulating microfilariae, not a history of loiasis per se, tracked with a blunted cellular response to SARS-CoV-2 spike antigen. The occult group, whose infections were not producing blood-borne larvae, did not show the same suppression.

Equally notable was what the study did not find. IgG antibody responses to spike and nucleocapsid did not differ among the three groups. The humoral arm of immunity, at least as measured by these ELISA-based assays, appeared intact regardless of Loa loa status. This dissociation between preserved antibody responses and diminished T cell cytokine production fits with what is known about helminth-induced immunomodulation, which tends to target cell-mediated inflammatory pathways more directly than B cell differentiation. It also raises practical questions, because many diagnostic and surveillance tools for COVID-19 rely on antibody measurements, which would miss this T cell-level difference entirely.

The implications extend beyond the laboratory. Interferon-gamma responses are a cornerstone of protective immunity against viral infections, and reduced T cell reactivity could, in principle, influence the course of SARS-CoV-2 infection or the effectiveness of vaccines in affected populations. The authors of the study are careful about causality: this was a cross-sectional observational study, so it demonstrates an association between microfilaremia and hyporesponsiveness rather than proving that the worms directly cause the immune deficit. Even so, the finding suggests that microfilaremic loiasis may impair proinflammatory T cell responses to viral antigens, a conclusion with real relevance for the millions of people in Central and West Africa who carry the parasite.

Loa loa is endemic across a broad swath of Central and West Africa, overlapping geographically with other filarial infections such as onchocerciasis and lymphatic filariasis, as well as with numerous other pathogens. If active microfilaremia systematically dampens antiviral T cell immunity, then endemic communities might respond differently to viral infections and to vaccination campaigns than populations free of helminth burden. Such effects have been debated in the context of other helminths, with studies of deworming and vaccine responses yielding mixed results across parasites and vaccines. The Gabonese data add loiasis to that conversation with a specific, quantified signal: a measurable reduction in IFN-γ release among microfilaremic individuals, absent in those with occult disease or no active infection.

The study’s authors emphasize that further research is needed to understand the broader immunological consequences of Loa loa infection in endemic populations. Key questions remain open. Does the T cell hyporesponsiveness translate into worse clinical outcomes after SARS-CoV-2 infection? Is it reversible, for example after anthelminthic treatment clears microfilariae from the blood? Does it extend to other viral antigens, or to vaccine-induced responses? And what mechanistic pathways, from regulatory T cells to suppressive cytokines to altered antigen presentation, connect circulating larvae to suppressed IFN-γ production? Answering these questions will require longitudinal designs and mechanistic immunology, but the present study provides a clear starting point: in Gabonese villages where Loa loa still thrives, the worms in the bloodstream appear to leave a fingerprint on the immune system’s response to a very different kind of invader.

Subject of Research: The effect of microfilaremic loiasis on T cell and antibody responses to SARS-CoV-2 infection

Article Title: Microfilaremic loiasis is associated with T cell hyporesponsiveness against SARS-CoV-2

Article References: Augé Stock, M., Okwu, D. G., More, A., Doralt, A., Bikangui, R., Boussoukou, I. P. M., Eberhardt, K. A., Sandkuhl, M., Zoleko Manego, R., Mombo-Ngoma, G., McCall, M., Breloer, M., Esen, M., Addo, M., Lell, B., Veletzky, L., Adamou, R., & Mackroth, M. S. (2026). Microfilaremic loiasis is associated with T cell hyporesponsiveness against SARS-CoV-2. PLOS Neglected Tropical Diseases, 20(10), e0014104. https://doi.org/10.1371/journal.pntd.0014104

Image Credits: AI Generated

DOI: 10.1371/journal.pntd.0014104

Keywords: loiasis, Loa loa, SARS-CoV-2, T cell hyporesponsiveness, microfilaremia, interferon-gamma, helminth immunomodulation, Gabon, neglected tropical diseases, IgG antibodies, filarial infection, COVID-19 immunity